# FDA Approval: Maintenance Lurbinectedin for SCLC

An episode of [Lung Cancer Considered](https://invisiblenetwork.ai/podcast/1655997630), 7 Oct 2025, 38 min.

Audio: https://feeds.soundcloud.com/stream/2183875539-lungcancerconsidered-fda-approval-maintenance-lurbinectedin-for-sclc.mp3

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of maintenance lurbinectedin plus atezolizumab for extensive stage small cell lung cancer, based on the phase III IMforte trial. Dr. Hossein Borghaei joins the podcast to explain the results and offer perspective on the impact of maintenance therapy for SCLC. Guest: Dr. Hossein Borghaei, DO, MS Chief, Division of Thoracic Medical Oncology Professor, Department of Hematology/Oncology Fox Chase Cancer Center

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.